AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
- 21 March 2013
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 41 (2) , 687-693
Abstract
AMPK (AMP-activated protein kinase) is a sensor of cellular energy status that appears to have arisen during early eukaryotic evolution. In the unicellular eukaryote Saccharomyces cerevisiae, the AMPK orthologue is activated by glucose starvation and is required for the switch from glycolysis (fermentation) to oxidative metabolism when glucose runs low. In mammals, rapidly proliferating cells (including tumour cells) and immune cells involved in inflammation both tend to utilize rapid glucose uptake and glycolysis (termed the Warburg effect or aerobic glycolysis) rather than oxidative metabolism to satisfy their high demand for ATP. Since mammalian AMPK, similar to its yeast orthologue, tends to promote the more energy-efficient oxidative metabolism at the expense of glycolysis, it might be expected that drugs that activate AMPK would inhibit cell proliferation and and hence cancer, as well as exerting anti-inflammatory effects. Evidence supporting this view is discussed, including our findings that AMPK is activated by the classic anti-inflammatory drug salicylate.Keywords
This publication has 50 references indexed in Scilit:
- Reductive carboxylation supports growth in tumour cells with defective mitochondriaNature, 2011
- TLR signalling augments macrophage bactericidal activity through mitochondrial ROSNature, 2011
- Structure of mammalian AMPK and its regulation by ADPNature, 2011
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK ActivationCell Metabolism, 2010
- Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cellsJournal of Biotechnology, 2009
- AMP-activated protein kinase adapts rRNA synthesis to cellular energy supplyProceedings of the National Academy of Sciences of the United States of America, 2009
- mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndromeProceedings of the National Academy of Sciences, 2009
- Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell ProliferationMolecular Cell, 2009
- AMPK Phosphorylation of Raptor Mediates a Metabolic CheckpointMolecular Cell, 2008
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerNature Medicine, 2005